Jane Street Group, LLC Ascendis Pharma A/S Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$113.0 - $153.43 $8.78 Million - $11.9 Million	77,700 New	77,700 $11.6 Million
Q1 2022 May 17, 2022	BUY	$102.18 - $135.75 $2.5 Million - $3.33 Million	24,500 Added 145.83%	41,300 $4.85 Million
Q4 2021 Feb 15, 2022	SELL	$127.1 - $169.66 $1.82 Million - $2.43 Million	-14,300 Reduced 45.98%	16,800 $2.26 Million
Q3 2021 Nov 16, 2021	BUY	$112.67 - $176.92 $2.82 Million - $4.42 Million	25,000 Added 409.84%	31,100 $4.96 Million
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $474,318 - $566,631	3,900 Added 177.27%	6,100 $802,000
Q1 2021 May 18, 2021	SELL	$124.92 - $173.33 $2.36 Million - $3.28 Million	-18,900 Reduced 89.57%	2,200 $284,000
Q4 2020 Feb 17, 2021	BUY	$151.2 - $182.76 $3.19 Million - $3.86 Million	21,100 New	21,100 $3.52 Million

243

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.